Evidence that nor-binaltorphimine (nor-BNI) can function as an antagonist at 
multiple opioid receptor subtypes

Spanagel, R.; Almeida, O. F. X.; Bartl, C.; Shippenberg, T. S.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Evidence that nor-binaltorphimine (nor-BNI) can function as an antagonist at multiple opioid receptor subtypes

MPS-Authors

/persons/resource/persons80249

Almeida, O. F. X.
AG Almeida, Osborne, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Spanagel, R., Almeida, O. F. X., Bartl, C., & Shippenberg, T. S. (1994). Evidence that nor-binaltorphimine (nor-BNI) can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology, 264, 157-162.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8467-2

Abstract

There is no abstract available